Concepedia

Carol H. Hu

CH

Statistics

Publications

4

Citations

83

H-Index

4

Active since

2011

Affiliations

Bristol-Myers Squibb (United States)(Current)

Carol H. Hu is an author at Bristol-Myers Squibb (United States) specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

2011–2021

4

Publications

4

Transformation of Anionically Activated Trifluoromethyl Groups to Heterocycles under Mild Aqueous Conditions

Jennifer X. Qiao, Tammy C. Wang, Carol H. Hu et al. · Organic Letters · 2011 · 44 citations

Small molecule and macrocyclic pyrazole derived inhibitors of myeloperoxidase (MPO)

Carol H. Hu, Meriah W. N. Valente, Otto Halpern et al. · Bioorganic & Medicinal Chemistry Letters · 2021 · 15 citations · Full text

, , +10

4‐Benzothiazole‐7‐hydroxyindolinyl Diaryl Ureas Are Potent P2Y<sub>1</sub> Antagonists with Favorable Pharmacokinetics: Low Clearance and Small Volume of Distribution

Jennifer X. Qiao, Tammy C. Wang, Sheldon Hiebert et al. · ChemMedChem · 2014 · 13 citations

2-Amino-1,3,4-thiadiazoles in the 7-hydroxy-N-neopentyl spiropiperidine indolinyl series as potent P2Y1 receptor antagonists

Carol H. Hu, Jennifer X. Qiao, Ying Han et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 11 citations · Full text

, , +4

1–4 of 4